Synthesis, Structure–Activity Relationship Study, Bioactivity, and Nephrotoxicity Evaluation of the Proposed Structure of the Cyclic Lipodepsipeptide Brevicidine B
Dennise Palpal-latoc,Aimee J. Horsfall,Alan J. Cameron,Georgia Campbell,Scott A. Ferguson,Gregory M. Cook,Veronika Sander,Alan J. Davidson,Paul W. R. Harris,Margaret A. Brimble
DOI: https://doi.org/10.1021/acs.jnatprod.3c00876
IF: 5.1
2024-02-29
Journal of Natural Products
Abstract:The brevicidines represent a novel class of nonribosomal antimicrobial peptides that possess remarkable potency and selectivity toward highly problematic and resistant Gram-negative pathogenic bacteria. A recently discovered member of the brevicidine family, coined brevicidine B (<b>2</b>), comprises a single amino acid substitution (from d-Tyr<sup>2</sup> to d-Phe<sup>2</sup>) in the amino acid sequence of the linear moiety of brevicidine (<b>1</b>) and was reported to exhibit broader antimicrobial activity against both Gram-negative (MIC = 2-4 μgmL<sup>-1</sup>) and Gram-positive (MIC = 2-8 μgmL<sup>-1</sup>) pathogens. Encouraged by this, we herein report the first total synthesis of the proposed structure of brevicidine B (<b>2</b>), building on our previously reported synthetic strategy to access brevicidine (<b>1</b>). In agreement with the original isolation paper, pleasingly, synthetic <b>2</b> demonstrated antimicrobial activity toward <i>Escherichia coli</i>, <i>Pseudomonas aeruginosa</i>, and <i>Klebsiella pneumoniae</i> (MIC = 4-8 μgmL<sup>-1</sup>). Interestingly, however, synthetic <b>2</b> was inactive toward all of the tested Gram-positive pathogens, including methicillin-resistant <i>Staphylococcus aureus</i> strains. Substitution of d-Phe<sup>2</sup> with its enantiomer, and other hydrophobic residues, yields analogues that were either inactive or only exhibited activity toward Gram-negative strains. The striking difference in the biological activity of our synthetic <b>2</b> compared to the reported natural compound warrants the re-evaluation of the original natural product for purity or possible differences in relative configuration. Finally, the evaluation of synthetic <b>1</b> and <b>2</b> in a human kidney organoid model of nephrotoxicity revealed substantial toxicity of both compounds, although <b>1</b> was less toxic than <b>2</b> and polymyxin B. These results indicate that modification to position 2 may afford a strategy to mitigate the nephrotoxicity of brevicidine.
plant sciences,chemistry, medicinal,pharmacology & pharmacy